ALKBH5 and osteosarcoma: However, ALKBH5 is downregulated in bladder cancer, pancreatic cancer, and osteosarcoma, and ALKBH5 overexpression markedly reduces the proliferative, migratory, and invasive features of those cancer cells 13-15.